Human Longevity Inc.
Healthcare company using genomics, machine learning, and clinical data to provide comprehensive health assessments and predict disease risk for longevity optimization.
Notes
Human Longevity Inc. (HLI) was founded in 2013 by genomics pioneer J. Craig Venter with the mission to extend healthy human lifespan using genomics, advanced diagnostics, and machine learning. The company offers comprehensive health assessments called "Health Nucleus" that combine whole genome sequencing, full-body MRI, advanced biomarkers, and AI-powered analysis.
The company built one of the largest databases of whole human genomes combined with phenotype data. HLI's approach aims to detect diseases at their earliest stages when interventions are most effective, particularly for conditions like cancer, cardiovascular disease, and metabolic disorders.
HLI has undergone management changes since its founding, with Venter stepping back from day-to-day operations. The company has pivoted more toward executive health assessments and concierge medicine.
Team
- J. Craig Venter, Ph.D. - Co-founder & Executive Chairman (genomics pioneer, first to sequence human genome privately)
- Robert Hariri, M.D., Ph.D. - Co-founder (also co-founded Celularity)
- Leadership has evolved since founding
Additional Research Findings
- Founded in 2013 in San Diego, California
- Co-founded by genomics legend J. Craig Venter
- Health Nucleus: comprehensive health assessment program
- Whole genome sequencing + full-body MRI + AI analysis
- Built large genome + phenotype database
- Focus on early disease detection
- Executive health and longevity optimization
- TVM Capital Healthcare portfolio company
- Raised over $300 million in early funding
- Multiple pivots in business model over time
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| TVM Capital Healthcare | Dubai, UAE & Munich, Germany | biotech-focused | series-aseries-b+1 | 10 |